Related Experiment Video
Updated: Feb 26, 2026

06:16
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
Published on: April 19, 2024
1.9K
Enhanced Fibrinolysis with Magnetically Powered Colloidal Microwheels
Tonguc O Tasci1, Dante Disharoon1, Rogier M Schoeman1
1Chemical and Biological Engineering Department, Colorado School of Mines, 1500 Illinois St., Golden, CO, 80401, USA.
Small (Weinheim an Der Bergstrasse, Germany)
|July 19, 2017
Summary
Magnetic microwheels deliver high concentrations of tissue-type plasminogen activator (tPA) for rapid, targeted thrombus dissolution. Their unique motion enhances fibrinolysis by mechanical penetration and surface lysis, overcoming diffusion limitations.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Hematology
Background:
- Thrombus resolution relies on fibrinolytic agents to degrade fibrin, but delivery and penetration are limited.
- Current fibrinolysis methods face challenges in reaching and effectively dissolving blood clots.
Purpose of the Study:
- To overcome transport limitations in fibrinolysis using magnetically actuated colloidal microwheels.
- To enhance the speed and efficacy of thrombus dissolution through targeted delivery and mechanical action.
Main Methods:
- Development of colloidal microwheel assemblies functionalized with tissue-type plasminogen activator (tPA).
- Utilizing applied magnetic fields to control microwheel assembly, rotation, translation, and disassembly.
- Investigating fibrinolysis rates in plasma-derived fibrin gels and microfluidic models of platelet-rich thrombi.
Main Results:
- tPA-microwheels achieved fivefold faster fibrinolysis of fibrin gels compared to free tPA.
- Microwheels demonstrated mechanical penetration into 100 µm platelet-rich thrombi within approximately 5 minutes.
- Demonstrated a combined surface and bulk dissolution mechanism with mechanical action.
Conclusions:
- Magnetically guided microwheels offer a novel strategy for rapid and targeted fibrinolysis.
- This approach overcomes diffusion limitations, showing potential for treating occlusions in small or deep vessels.
- Microwheel technology presents a promising advancement over traditional fibrinolytic therapies.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Clot Retraction and Fibrinolysis
9.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.6K
Coagulation
1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K

